Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polycythemia Vera (PV)”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Not applicableNot Yet RecruitingNCT06785870
What this trial is testing

EVAluation of Erythrocytosis PRospEctive Cohort STudy

Who this might be right for
ErythrocytosisPolycythemiaPolycythemia Secondary+5 more
Cyrus Hsia 1,500
Not applicableLooking for participantsNCT06743035
What this trial is testing

Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly

Who this might be right for
Polycythemia Vera
iOMEDICO AG 200
Testing effectiveness (Phase 2)Looking for participantsNCT05870475
What this trial is testing

Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV

Who this might be right for
Polycythemia Vera
Institute of Hematology & Blood Diseases Hospital, China 94
Post-approval studies (Phase 4)Active Not RecruitingNCT02386800
What this trial is testing

CINC424A2X01B Rollover Protocol

Who this might be right for
Primary MyelofibrosisPolycythemia VeraGraft Versus Host Disease+2 more
Novartis Pharmaceuticals 279
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07750574
What this trial is testing

Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis

Who this might be right for
MyelofibrosisMyelofibrosis Due to and Following Polycythemia VeraMyelofibrosis Transformation in Essential Thrombocythemia+9 more
Chengdu Zenitar Biomedical Technology Co., Ltd 105
Large-scale testing (Phase 3)Active Not RecruitingNCT05481151
What this trial is testing

Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

Who this might be right for
Polycythemia Vera
PharmaEssentia 111
Early research (Phase 1)Not Yet RecruitingNCT07529951
What this trial is testing

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

Who this might be right for
Polycythemia Vera (PV)Myelofibrosis (MF)
Eilean Therapeutics 60
Not applicableStudy completedNCT01970930
What this trial is testing

Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients

Who this might be right for
Polycythemia VeraEssential Thrombocythemia
Icahn School of Medicine at Mount Sinai 131
Testing effectiveness (Phase 2)Study completedNCT05558696
What this trial is testing

Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004)

Who this might be right for
Polycythemia Vera
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05485948
What this trial is testing

Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU

Who this might be right for
Polycythemia Vera
PharmaEssentia 49
Testing effectiveness (Phase 2)Ended earlyNCT02410551
What this trial is testing

Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)

Who this might be right for
Myeloproliferative Diseases
M.D. Anderson Cancer Center 4
Large-scale testing (Phase 3)UnknownNCT03662126
What this trial is testing

KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment

Who this might be right for
Primary Myelofibrosis (PMF)Post-Polycythemia Vera MF (Post-PV-MF)Post-Essential Thrombocythemia MF (Post-ET-MF)
Kartos Therapeutics, Inc. 385
Not applicableStudy completedNCT04177576
What this trial is testing

Evaluation of New Biomarkers of Thrombosis in Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasm
University Hospital, Bordeaux 397
Not applicableStudy completedNCT00715247
What this trial is testing

Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes

Who this might be right for
Polycythemia VeraEssential ThrombocythemiaMyelofibrosis
University of Utah 726
Not applicableNo Longer AvailableNCT05269771
What this trial is testing

MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Looking for participantsNCT06093672
What this trial is testing

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

Who this might be right for
Polycythemia Vera
Italfarmaco 220
Post-approval studies (Phase 4)WithdrawnNCT06290765
What this trial is testing

Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera

Who this might be right for
Polycythemia VeraMyeloproliferative Neoplasm
PharmaEssentia
Not applicableLooking for participantsNCT07445893
What this trial is testing

A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

Who this might be right for
Polycythemia Vera (PV)
Duan Minghui 30
Testing effectiveness (Phase 2)Study completedNCT03003325
What this trial is testing

The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV

Who this might be right for
Polycythemia Vera
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 127
Testing effectiveness (Phase 2)Ended earlyNCT01668173
What this trial is testing

HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/ET

Who this might be right for
Myeloproliferative Neoplasms
Memorial Sloan Kettering Cancer Center 7
Next Page